Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
Royalty Pharma stock last closed at $60.59, up 0% from the previous day, and has increased 66% in one year. It has overperformed other stocks in the Biotechnology industry by 0.76 percentage points. Royalty Pharma stock is currently +74.96% from its 52-week low of $34.63, and -5.89% from its 52-week high of $64.38.
As of Sep 9, 2026, there are 575M RPRX shares outstanding. The market capitalization of RPRX is $34.84B. In the past 24 hours, 4.34M RPRX shares were traded.
How to Buy Royalty Pharma Stock
Not sure how to invest in Royalty Pharma stock? Here's how.
Decide where to buy Royalty Pharma stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Royalty Pharma stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit money your investment account: Choose your payment method and add your details.
Analyze Royalty Pharma stock: The Royalty Pharma ticker symbol is RPRX. Is Royalty Pharma stock a good investment? Should you buy shares of RPRX? How do RPRX's underlying business fundamentals look? Do top analysts think Royalty Pharma is a good buy? Why has RPRX's stock price moved recently? (Hint: Our stock research tools can help you understand if RPRX is a good stock to buy).
Execute your RPRX purchase: Decide if you will purchase RPRX shares at the current market price or use a limit order to purchase RPRX stock at a given price.
Keep tabs on your RPRX position: Create a watchlist to get the latest news on your new investment in Royalty Pharma stock.
Step 1: Decide where to buy Royalty Pharma stock
You will need a brokerage account in order to access the NASDAQ market and buy RPRX shares.
A brokerage account is an investment account that allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
In our opinion, eToro is the best place to buy stocks. Here's why:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world financial markets: From Tech to Energy, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you are able to buy RPRX today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Royalty Pharma stock
After you have identified the best place to buy Royalty Pharma stock, it's critical to research their stock before you buy, so you truly understand the risk as well as the upside.
Overview of key RPRX info
RPRX Price
$60.59
1w %
-3.99%
1y %
66%
5y %
58.24%
P/E
32.23x
P/B
3.56x
P/S
10.63x
PEG
0.65x
Revenue
$2.54B
Earnings
$815.00M
Fore. Rev. Growth
15.38%
Fore. Earn. Growth
49.21%
Market Cap
$34.84B
Next Earnings
N/A
Next Dividend
Sep 10, 2026
Royalty Pharma Overview
WallStreetZen was designed to help everyday investors do better fundamental analysis in less time.
There are more short-term assets than short-term liabilities on the RPRX balance sheet.
RPRX's operating cash flow of $2.98B allows it to safely service it's debt of $8.96B.
Failed Financial Due Diligence Checks:
RPRX earnings of $1.18B is not sufficient to cover its interest payments.
There are more long-term liabilities than short-term assets on the RPRX balance sheet.
Total RPRX debt is higher than 5 years ago, relative to shareholder equity.
RPRX has a relatively high debt to equity ratio of 1.03.
RPRX profit margin has gone down from 44.4% to 32.1% in the past year.
Do analysts think it's a good time to buy RPRX stock
Out of 6 Wall Street analysts who monitor RPRX, the consensus analyst rating on Royalty Pharma is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent RPRX Analyst Recommendations
Terence Flynn, a top 5% analyst from Morgan Stanley maintains RPRX with a strong buy rating and raises their RPRX price target from $61.00 to $63.00, on Apr 10, 2026.
Morgan Stanley's Terence Flynn raised their price target on Royalty Pharma (NASDAQ: RPRX) by 3.3% from $61 to $63 on 2026/04/10. The analyst maintained their Strong Buy rating on the stock.
Royalty Pharma is expected to report its Q1 2026 earnings on 2026/05/07.
Raising their price target in a Biopharma sector preview note, Flynn said they adjusted group models to reflect "IQVIA trends as well as intra-quarter updates."
Last year, RPRX earnings were $815.00M. Over the past five year, RPRX's earnings have grown by -5.47% per year. This was slower than the Biotechnology industry average of 9.73%.
Last year, RPRX revenue was $2.54B. Over the last five year, RPRX's revenue has grown by 2.53% per year. This was slower than the Biotechnology industry average of 23.67%.
Royalty Pharma pays a dividend of 1.53%, compared to the Biotechnology industry's average dividend yield of 11.81%. If you owned $1,000 worth of RPRX stock, you would have received $15.27 last year.
Royalty Pharma dividend payments have consistently grown over the past 6 years and have remained stable.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Execute your RPRX purchase
You have two main order types:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are mostly sufficient.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact price limit, place a limit order.
Hit the Open button and eToro will place the order.
If you need more help buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Royalty Pharma share?
As of Sep 9, 2026, it costs $60.59 to buy one share of Royalty Pharma stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.165 shares of RPRX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.